A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Clinical trial NCT06422884 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06422884
Sponsor: Endeavor Biomedicines, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease

Start date: 2024-11-15
Primary completion: 2026-10-01
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.